TerrAscend (TSNDF) Receivables - Other (2021 - 2026)
TerrAscend's (TSNDF) quarterly Receivables - Other came in at $1.1 million in Q1 2026, down 34.15% year-on-year from $1.7 million in Q1 2025, and up 88.65% on a QoQ basis from $599000.0 in Q4 2025.
TerrAscend (TSNDF) Receivables - Other (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Receivables - Other data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Receivables - Other fell 34.15% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 34.15% decrease from a year earlier, with the FY2025 full-year figure at $599000.0, up 6.39% from the prior year.
- Receivables - Other for Q1 2026 stood at $1.1 million, up from $599000.0 in the prior quarter.
- Over the last five years, Receivables - Other for TSNDF reached as high as $17.9 million in Q4 2022 and fell as low as $181000.0 in Q3 2024.
- Historically, Receivables - Other has averaged $1.8 million across 5 years, with a median of $602000.0 in 2022.
- Across the five-year window, Receivables - Other soared 4747.57% in 2022 and slumped 93.57% in 2023, its largest moves.
- Year by year, Receivables - Other stood at $17.9 million in 2022, then slumped by 93.57% to $1.2 million in 2023, then sank by 51.21% to $563000.0 in 2024, then rose by 6.39% to $599000.0 in 2025, then soared by 88.65% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $1.1 million in Q1 2026, $599000.0 in Q4 2025, and $538000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 599,000.00 |
| Dec 31, 2025 | 599,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 563,000.00 |
| Dec 31, 2024 | 563,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Jun 30, 2024 | 530,000.00 |
| Jun 30, 2024 | 530,000.00 |
| Mar 31, 2024 | 887,000.00 |
| Mar 31, 2024 | 887,000.00 |
| Dec 31, 2023 | 1.15 Mn |
| Dec 31, 2023 | 1.15 Mn |